News for hackers. Stuff that matters.
Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by rguiscard on Tuesday January 25, 2022 @04:25AM (#30069931)
Several authors are in Insilico Medicine[1], which uses AI for drug discovery and has one product in clinical trials if I remember correctly.

[1] https://insilico.com/

Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by bayesian_horse on Tuesday January 25, 2022 @06:09AM (#30070527)
This paper doesn't use Machine Learning at all, as far as I understand it.
Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by fnands on Tuesday January 25, 2022 @07:06AM (#30070887)
It does. They used Chemistry42 which is Insilico's ML based molecule generation platform(?)[0]. Sure, they didn't train any models specifically for this case, but they used a protein structure predicted by one ML algorithm, then used another set of ML algorithms to find and rank molecules that might match the protein, and then tested the most likely ones in reality.

[0] https://arxiv.org/pdf/2101.09050.pdf